Tech roundup / Even the board at Alvarion has given up
Alvarion circles the drain, FIMI extends its option on El Al, Redhill takes its antinausea drug to the FDA.
Summer seems more the time to swim in the sultry sea, becoming one with the mermaids, or jellyfish if you're not the romantic type. Judging by the action it seems less a season for investing in startups. Yet some business goes on despite the summer heat - that's what air conditioners are for – except at Alvarion, for one. Read on.